IOVA - IOVANCE BIOTHERAPEUTICS, INC.

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 13.39

Open

$ 13.72

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 13.12 - $ 13.86

52 Week Range

$ 3.21 - $ 18.33

Volume

4,195,241

Average Volume

Market Cap

3.15B

Beta (5Y Monthly)

$ 1.17

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-28-2024	12-31-2023	10-K
2	11-07-2023	09-30-2023	10-Q
3	08-08-2023	06-30-2023	10-Q
4	05-10-2023	03-31-2023	10-Q
5	02-28-2023	12-31-2022	10-K
6	11-03-2022	09-30-2022	10-Q
7	08-04-2022	06-30-2022	10-Q
8	05-05-2022	03-31-2022	10-Q
9	02-24-2022	12-31-2021	10-K
10	11-04-2021	09-30-2021	10-Q
11	08-05-2021	06-30-2021	10-Q
12	05-06-2021	03-31-2021	10-Q
13	02-25-2021	12-31-2020	10-K
14	11-05-2020	09-30-2020	10-Q
15	08-06-2020	06-30-2020	10-Q
16	05-05-2020	03-31-2020	10-Q
17	02-25-2020	12-31-2019	10-K
18	11-04-2019	09-30-2019	10-Q
19	08-01-2019	06-30-2019	10-Q
20	05-07-2019	03-31-2019	10-Q
21	02-28-2019	12-31-2018	10-K
22	11-06-2018	09-30-2018	10-Q
23	08-07-2018	06-30-2018	10-Q
24	05-10-2018	03-31-2018	10-Q
25	03-12-2018	12-31-2017	10-K
26	11-02-2017	09-30-2017	10-Q
27	08-03-2017	06-30-2017	10-Q
28	05-03-2017	03-31-2017	10-Q
29	03-09-2017	12-31-2016	10-K
30	11-04-2016	09-30-2016	10-Q
31	08-09-2016	06-30-2016	10-Q
32	05-09-2016	03-31-2016	10-Q
33	03-11-2016	12-31-2015	10-K
34	11-06-2015	09-30-2015	10-Q
35	08-10-2015	06-30-2015	10-Q
36	05-11-2015	03-31-2015	10-Q
37	03-16-2015	12-31-2014	10-K
38	11-13-2014	09-30-2014	10-Q
39	08-08-2014	06-30-2014	10-Q
40	05-14-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

AHN Cancer Institute To Offer Groundbreaki...
04/22/2024 12:49:08

Allegheny Health Network (AHN) Cancer Institute has become the first health care system in Western Pennsylvania to offer a firs...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
03/19/2024 17:35:23

Piper Sandler Maintains Overweight Rating ...
03/14/2024 17:00:32

Piper Sandler Maintains Overweight on Iova...
03/14/2024 14:26:14

Piper Sandler analyst Joseph Catanzaro maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Overweight and raises the pric...

unpacking-the-latest-options-trading-trends-in-iovance-biotherapeutics

Unpacking the Latest Options Trading Trend...
03/13/2024 16:16:02

Truist Securities Maintains Buy Rating for...
03/07/2024 17:00:13

Truist Securities Maintains Buy on Iovance...
03/07/2024 16:55:38

Truist Securities analyst Asthika Goonewardene maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and raises the pri...

HC Wainwright & Co. Reiterates Buy on Iova...
03/04/2024 14:44:34

HC Wainwright & Co. analyst Joseph Pantginis reiterates Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and maintains $...

The FDA Has Lifted A Partial Clinical Hold...
03/04/2024 11:35:16

iova---analyzing-iovance-biotherapeuticss-short-interest

(IOVA) - Analyzing Iovance Biotherapeutics...
03/01/2024 14:15:18

Wells Fargo Maintains Overweight on Iovanc...
03/01/2024 13:04:47

Wells Fargo analyst Yanan Zhu maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Overweight and raises the price target ...

HC Wainwright & Co. Reiterates Buy on Iova...
02/29/2024 20:38:25

HC Wainwright & Co. analyst Joseph Pantginis reiterates Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and maintains $...

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
02/29/2024 17:35:24

spotlight-on-iovance-biotherapeutics-analyzing-the-surge-in-options-activity

Spotlight on Iovance Biotherapeutics: Anal...
02/29/2024 17:01:21

Goldman Sachs Maintains Buy on Iovance Bio...
02/29/2024 15:01:12

Goldman Sachs analyst Andrea Tan maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and raises the price target from...

Barclays Maintains Overweight on Iovance B...
02/29/2024 13:41:00

Barclays analyst Peter Lawson maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Overweight and raises the price target ...

Iovance Biotherapeutics Q4 EPS $(0.45) Mis...
02/28/2024 21:06:09

Iovance Biotherapeutics (NASDAQ:IOVA) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimat...

Iovance Biotherapeutics: Q4 Earnings Insights
02/28/2024 21:05:17

Earnings Scheduled For February 28, 2024
02/28/2024 11:24:02

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

Iovance Biotherapeutics's Earnings: A Preview
02/27/2024 19:01:50